{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:12:25Z","timestamp":1789823545766,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.heliyon.2024.e38807","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T23:20:49Z","timestamp":1727824849000},"page":"e38807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive treatment of primary pelvic synovial sarcoma: A 28-month follow-up case report and review of the literature"],"prefix":"10.1016","volume":"10","author":[{"given":"Zhiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e38807_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biocel.2014.05.006","article-title":"Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features","volume":"53","author":"Przybyl","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jso.23780","article-title":"Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: a SEER analysis","volume":"111","author":"Naing","year":"2015","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/2309499020936009","article-title":"Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis","volume":"28","author":"Aytekin","year":"2020","journal-title":"J. Orthop. Surg."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.09.002","article-title":"Synovial sarcoma: defining features and diagnostic evolution","volume":"18","author":"Thway","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"issue":"15","key":"10.1016\/j.heliyon.2024.e38807_bib5","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/cncr.24424","article-title":"Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients","volume":"115","author":"Sultan","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38807_bib6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/curroncol28030177","article-title":"Synovial sarcoma: a clinical review","volume":"28","author":"Gazendam","year":"2021","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radcr.2018.10.026","article-title":"Synovial sarcoma of bone: sarcoma typically of soft tissues presenting as a primary bone tumor","volume":"14","author":"Caracciolo","year":"2018","journal-title":"Radiol Case Rep"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38807_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PGP.0000000000000892","article-title":"Two cases of biphasic synovial sarcoma with expression of PAX8 and er: a diagnostic pitfall","volume":"42","author":"Zheng","year":"2023","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38807_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.31486\/toj.22.0046","article-title":"Pelvic synovial sarcoma clinically masquerading as an ovarian malignancy","volume":"23","author":"Gupta","year":"2023","journal-title":"Ochsner J."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib10","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1055\/s-0042-1758052","article-title":"Unusual cause of acute urinary retention in young male patient: primary synovial sarcoma of prostate-A case report","volume":"8","author":"Bandegudda","year":"2022","journal-title":"Surg. J."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-4.19072","article-title":"Primary ovarian synovial sarcoma - a case report","volume":"44","author":"Yordanov","year":"2022","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38807_bib12","first-page":"99","article-title":"Poorly differentiated synovial sarcoma of the vagina: a case report and a clinical literature review","volume":"2","author":"Minig","year":"2008","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38807_bib13","first-page":"185","article-title":"Monophasic synovial sarcoma as a cause of obstructive ileus: a case report","volume":"10","author":"Ioannidis","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4103\/0377-4929.125336","article-title":"Dumb-bell shaped poorly differentiated pelvic synovial sarcoma with molecular confirmation: a rare presentation of an uncommon disease entity","volume":"56","author":"Hasan","year":"2013","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e38807_bib15","article-title":"Monophasic synovial sarcoma of prostatic fascia: case report and literature review","volume":"2015","author":"Olivetti","year":"2015","journal-title":"Case Rep Urol"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0019-509X.41774","article-title":"A t(X; 18) SYT-SSX2 positive synovial sarcoma in the pelvis of a young adult male: a rare case report with review of literature","volume":"45","author":"Rekhi","year":"2008","journal-title":"Indian J. Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38807_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pgp.0000225841.13880.3a","article-title":"Primary synovial sarcoma in fallopian tube: case report and literature review","volume":"26","author":"Mitsuhashi","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib18","first-page":"512","article-title":"Primary rectal monophasic synovial sarcoma","volume":"34","author":"Zhang","year":"2021","journal-title":"SAVE Proc."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib19","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1177\/00031348221074221","article-title":"Primary synovial sarcoma of the rectum","volume":"89","author":"Williams","year":"2023","journal-title":"Am. Surg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38807_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-023-01367-z","article-title":"Synovial sarcoma of female urethra: a case report and review of the literature","volume":"18","author":"Cui","year":"2023","journal-title":"Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12253-011-9391-x","article-title":"Primary synovial sarcoma of the uterus","volume":"18","author":"Dundr","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e38807_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-021-00914-4","article-title":"The biology of synovial sarcoma: state-of-the-art and future perspectives","volume":"22","author":"Fiore","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejso.2018.07.006","article-title":"Synovial sarcoma: do children do better?","volume":"45","author":"Smolle","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1046","key":"10.1016\/j.heliyon.2024.e38807_bib24","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140608","article-title":"Imaging features of primary and metastatic extremity synovial sarcoma: a single institute experience of 78 patients","volume":"88","author":"Baheti","year":"2015","journal-title":"Br. J. Radiol."},{"issue":"964","key":"10.1016\/j.heliyon.2024.e38807_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1259\/bjr\/28335824","article-title":"Radiological features of synovial cell sarcoma","volume":"81","author":"O'Sullivan","year":"2008","journal-title":"Br. J. Radiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/ol.2014.2774","article-title":"Synovial sarcoma: magnetic resonance and computed tomography imaging features and differential diagnostic considerations","volume":"9","author":"Liang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/PAT.0000000000000050","article-title":"WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition","volume":"46","author":"Jo","year":"2014","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e38807_bib28","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00264-020-04708-5","article-title":"The survival and prognosis analysis of synovial sarcoma subtypes: a Surveillance, Epidemiology, and End Results population-based analysis","volume":"44","author":"Xiong","year":"2020","journal-title":"Int. Orthop."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/sajc.sajc_269_17","article-title":"Clinicopathological features, treatment and survival outcomes of synovial sarcoma","volume":"7","author":"Kuruva","year":"2018","journal-title":"South Asian J Cancer"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.2017.75.1941","article-title":"Synovial sarcoma: current concepts and future perspectives","volume":"36","author":"Stacchiotti","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2159-8290.CD-14-1246","article-title":"Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy","volume":"5","author":"Nielsen","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10210","article-title":"A novel fusion gene, SS18L1\/SSX1, in synovial sarcoma","volume":"37","author":"Storlazzi","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38807_bib33","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.ejso.2022.05.022","article-title":"Metastasectomy in synovial sarcoma: a systematic review and meta-analysis","volume":"48","author":"Wang","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.6004\/jnccn.2016.0078","article-title":"Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"von Mehren","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38807_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","article-title":"Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"von Mehren","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.heliyon.2024.e38807_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00003086-199304000-00038","article-title":"Wound complication in surgery of soft tissue sarcoma. Analysis of 103 consecutive patients managed without adjuvant therapy","volume":"289","author":"Saddegh","year":"1993","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38807_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2010.06.034","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients","volume":"81","author":"Sampath","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38807_bib38","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.6806","article-title":"Neoadjuvant hypofractionated radiotherapy and chemotherapy in high-grade extremity soft tissue sarcomas: phase 2 clinical trial protocol","volume":"6","author":"Spencer","year":"2017","journal-title":"JMIR Res Protoc"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.02.5577","article-title":"Radiation Therapy Oncology Group Trial 9514. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation Therapy Oncology Group Trial 9514","volume":"24","author":"Kraybill","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib41","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1470-2045(17)30330-3","article-title":"Neoadjuvant chemotherapy in localised soft-tissue sarcomas: where do we go from here?","volume":"18","author":"van der Graaf","year":"2017","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38807_bib42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrclinonc.2017.118","article-title":"Sarcoma: does histotype-tailored neoadjuvant therapy improve outcomes?","volume":"14","author":"ones","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38807_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e38807_bib44","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.19.03289","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and polish (PSG) sarcoma groups","volume":"38","author":"Gronchi","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38807_bib45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jamaoncol.2023.0042","article-title":"Pathologic complete response and clinical outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy: the NRG\/RTOG 9514 and 0630 nonrandomized clinical trials","volume":"9","author":"Wang","year":"2023","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38807_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/CCO.0000000000000955","article-title":"New targeted treatments for advanced sarcomas","volume":"35","author":"Li","year":"2023","journal-title":"Curr. Opin. Oncol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e38807_bib47","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/cancers15082287","article-title":"Current landscape of immunotherapy for advanced sarcoma","volume":"15","author":"Albarr\u00e1n","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e38807_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1150765","article-title":"New therapeutics for soft tissue sarcomas: overview of current immunotherapy and future directions of soft tissue sarcomas","volume":"13","author":"Seong","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e38807_bib49","article-title":"miRNAs as biomarkers and possible therapeutic strategies in synovial sarcoma","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38807_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002072","article-title":"Targeting cancer testis antigens in synovial sarcoma","volume":"9","author":"Mitchell","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38807_bib51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41416-023-02416-6","article-title":"Axitinib in patients with advanced\/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata","volume":"129","author":"Woll","year":"2023","journal-title":"Br. J. Cancer"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:46:54Z","timestamp":1789822014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024148384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2405844024148384"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38807","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive treatment of primary pelvic synovial sarcoma: A 28-month follow-up case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38807"}}